Location: Champalimaud Centre for the Unknown, Lisbon
Employer: Champalimaud Foundation
Job Type: Full Time
Position: Postdoctoral Positions
Application Starts: 26 Jul. 2021

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Postdoctoral Researcher for Papanikolaou group.

Eligible candidates must hold a PhD or Doctorate degree and will be offered an employment contract with unknown term, within the scope of the research project entitled “ProCancer-i”; with the reference “952159” – from the call Nº H2020-SC1-FA-DTS-2019-1, funded by the European Union’s Horizon 2020 research and innovation programme.

The contract is to be entered into by and between the Champalimaud Foundation and the selected candidate in accordance with all applicable legislation, including Law-Decree 57/2016, of the 29 of August of 2016 in its current edition and the General Labour Code, as well as the internal rules and regulations of the Champalimaud Foundation, taking into account the conditions set out in the above mentioned Law-Decree for the recruitment of PhD Holders within the scope of research projects funded by public funds
Work Plan

Participate in the development of Deep Learning based models and Radiomics Signatures that will be extracted from mpMRI images from a total number of 17000 patients with prostate cancer, with a focus on statistical analysis concepts including but not limited to feature selection/reduction, ML modelling using survival analysis and other clinical outcomes.

Highlights

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

ProCAncer-I organised the 4th Dissemination Event of the project at the ECR 2025 held in Vienna, Austria, February 25-26, 2025. During the congress, ProCAncer-I organised a Dedicated Session on the project on the 26th of February 2025, at 15.00-16.00, with the title...

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

Twitter feed is not available at the moment.

Stay in touch!